What is the significance of a fasting serum gastrin level of 136 pg/mL and how should it be evaluated?

Gastrin Level of 136 pg/mL: Evaluation and Significance

A gastrin level of 136 pg/mL is mildly elevated but NOT diagnostic of gastrinoma and most likely represents a common benign cause such as proton pump inhibitor (PPI) use, atrophic gastritis, or H. pylori infection—you must first stop PPIs for at least 1 week and rule out these common causes before pursuing gastrinoma workup. 1, 2

Understanding the Context

The normal fasting serum gastrin (FSG) is typically <100 pg/mL. Your value of 136 pg/mL represents a mild elevation (<2-fold above normal), which falls into a diagnostic gray zone where gastrinoma is uncommon but other conditions are frequent.

Critical Diagnostic Thresholds

• FSG >1000 pg/mL with gastric pH <2: Diagnostic of gastrinoma 2
• FSG >10-fold elevated (typically >1000 pg/mL) with gastric pH <2: Diagnostic of gastrinoma 3
• FSG 100-1000 pg/mL: Requires further evaluation; overlaps with many benign conditions 1, 2, 4
• FSG <100 pg/mL: Gastrinoma highly unlikely 5

Your level of 136 pg/mL means gastrinoma is possible but uncommon—only about one-third of gastrinoma patients present with FSG <10-fold elevated 5.

Immediate Action Steps

1. Medication Review (CRITICAL FIRST STEP)

Stop PPIs for at least 1 week before repeating gastrin measurement 1, 2, 1, 2. PPIs are the most common cause of spuriously elevated gastrin levels and will confound diagnosis. If the patient has severe symptoms requiring acid suppression, substitute with H2-receptor antagonists during this period, but stop these 48 hours before testing 6.

Other medications/conditions causing false elevation:

• Renal failure
• Liver failure
• Hypertension medications
• Chronic gastritis 1, 2

2. Rule Out Common Causes

The vast majority of patients with mildly elevated gastrin do NOT have gastrinoma 1, 2. Evaluate for:

• H. pylori infection: Test and treat if positive 6, 7
• Atrophic gastritis: Particularly autoimmune gastritis (check parietal cell antibodies and intrinsic factor antibodies) 6, 7
• Achlorhydria/hypochlorhydria: From any cause 1, 2
• Prior gastric surgery: Including vagotomy or retained gastric antrum 6, 4
• Gastric outlet obstruction 4

3. Assess Clinical Context

Symptoms suggesting gastrinoma (Zollinger-Ellison syndrome):

• Severe, refractory peptic ulcer disease
• Multiple or atypical ulcer locations
• Chronic diarrhea (often accompanies dyspepsia)
• Recurrent ulcers despite H. pylori eradication
• GI bleeding from peptic ulcers 1, 2, 4

Family history: Screen for Multiple Endocrine Neoplasia type 1 (MEN1)—check calcium, parathyroid hormone, and prolactin 1, 6

If Gastrinoma Remains Suspected

Confirmatory Testing Algorithm

After stopping PPIs for ≥1 week:

1. Repeat fasting gastrin AND measure gastric pH 2

   • If FSG >1000 pg/mL AND gastric pH <2 → Gastrinoma confirmed
   • If FSG remains <10-fold elevated → Proceed to provocative testing

2. Secretin stimulation test (FIRST-LINE provocative test) 8

   • Positive criteria: Increase in gastrin ≥120 pg/mL post-secretin (sensitivity 94%, specificity 100%) 8
   • Alternative criterion: Increase >200 pg/mL (sensitivity 83%, specificity 100%) 2
   • This is more sensitive and safer than calcium testing

3. Calcium gluconate test (if secretin test negative but suspicion remains high) 8

   • Positive criteria: Increase in gastrin ≥395 pg/mL post-calcium (sensitivity 62%, specificity 100%)
   • 38-50% of patients with negative secretin tests have positive calcium tests 8

4. Upper endoscopy with biopsy 3

   • Look for signs of Zollinger-Ellison syndrome
   • Rule out atrophic gastritis
   • Follow updated Sydney protocol for biopsies if atrophic gastritis suspected 7

Tumor Localization (if gastrinoma confirmed)

• Multiphasic CT or MRI of abdomen 1, 2, 1
• Somatostatin receptor scintigraphy-PET (Gallium-68 DOTATOC): Current gold standard for localization 3, 4
• Endoscopic ultrasound (EUS): Particularly useful for pancreatic lesions (sensitivity 83%) but less sensitive for duodenal tumors 2, 4
• Chromogranin A level (category 3 evidence): May be elevated but can be falsely elevated by PPIs 1, 2

Common Pitfalls to Avoid

1. Pursuing gastrinoma workup without stopping PPIs first—this is the most common error 1, 2, 6
2. Assuming mild gastrin elevation equals gastrinoma—two-thirds of gastrinoma patients have FSG <10-fold elevated, but most patients with mild elevation don't have gastrinoma 5
3. Forgetting to check gastric pH—hypergastrinemia with high gastric pH suggests achlorhydria, not gastrinoma 2
4. Not screening for MEN1 in confirmed gastrinoma cases 1, 6

Most Likely Scenario

Given a gastrin of 136 pg/mL without additional context, the most probable diagnosis is PPI use or atrophic gastritis, NOT gastrinoma. 1, 2 Repeat testing off PPIs and evaluate for common causes before pursuing expensive imaging or provocative testing.